Hematopoetic stem cells

Developed for: beta thalassemia
Investigated by: Guangzhou Institutes of Biomedicine and Health Chinese Academy of Sciences · Nanfang Hospital, Southern Medical University · Third Affiliated Hospital, Sun Yat-Sen University · Xiaofang Sun

2015201620172018201920202021202220232024202520262027

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
—	NCT03222453	Jan 2015 → Jun 2016	beta thalassemia	Xiaofang Sun	Unknown	No outcome recorded

Every value below carries the sentence it was read from. 1 source stands behind the page.

Field	Value	Cited text
Known as	Hematopoetic stem cells	ClinicalTrials.gov intervention name — accepted as the source's own label NCT03222453 ↗